Recombinant human thrombopoietin therapy for primary immune thrombocytopenia in pregnancy: a retrospective comparative cohort study

BACKGROUND: Treatment options for pregnant women with immune thrombocytopenia (ITP) who do not respond to first-line treatment are limited. Few studies have reported the use of recombinant human thrombopoietin (rhTPO) for this subset of patients. AIMS: To investigate the efficacy and safety of rhTPO...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Jing, Wang, Tong-Fei, Huang, Mei-Juan, Huang, Hao-Bo, Chen, Pei-Fang, Zhou, Yu, Dai, Wei-Chao, Zhou, Ling, Feng, Xiu-Shan, Wang, Hui-Lan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10680270/
https://www.ncbi.nlm.nih.gov/pubmed/38012579
http://dx.doi.org/10.1186/s12884-023-06134-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10680270/
https://www.ncbi.nlm.nih.gov/pubmed/38012579
http://dx.doi.org/10.1186/s12884-023-06134-y

Ejemplares similares